Novartis is a Swiss multinational pharmaceutical company headquartered in Basel, Switzerland.
It was founded in 1996 from the merger of Ciba-Geigy and Sandoz Laboratories.
The company specializes in the development, manufacturing, and marketing of pharmaceuticals, generics, eye care products, and vaccines.
Novartis operates in over 140 countries worldwide and has a workforce of approximately 109,000 employees.
Its products are used to treat a range of diseases and conditions including cancer, heart diseases, respiratory illnesses, neurological disorders, and infectious diseases.
The company is committed to innovation and invests heavily in research and development.
It has a long history of bringing innovative medicines to market, including breakthrough therapies for cancer, multiple sclerosis, psoriasis, and heart disease.
Novartis is also dedicated to improving global health and access to healthcare.
It has various initiatives in place that focus on improving healthcare in low-income countries and addressing healthcare disparities.
This includes providing medicines at reduced prices, supporting disease awareness and prevention programs, and investing in local healthcare infrastructure and training.
Overall, Novartis is a leading pharmaceutical company with a strong focus on innovation, research and development, and improving global access to healthcare.